MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/dmrr.3787

Медицинская библиотека · Diabetes/metabolism research and reviews · 2024

Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.

Tavaglione Federica, Flagiello Valentina, Terracciani Francesca, Gallo Paolo, Capparelli Emma, Spiezia Chiara, De Vincentis Antonio, Palermo Andrea, Scriccia Sara, Galati Giovanni, Napoli Nicola, Daniels Samuel J, Blau Jenny E, Carlsson Björn, Khazrai Yeganeh M, Incalzi Raffaele Antonelli, Picardi Antonio, Vespasiani-Gentilucci Umberto

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

AIMS: Given the increasing number of individuals developing metabolic dysfunction-associated steatotic liver disease (MASLD) and the low rate of those with progressive liver disease, there is a pressing need to conceive affordable biomarkers to assess MASLD in general population settings. Herein, we aimed to investigate the performance of the ultrasound-derived fat fraction (UDFF) for hepatic steatosis in high-risk individuals.

METHODS

A total of 302 Europeans with obesity, type 2 diabetes, or a clinical history of hepatic steatosis were included in the analyses. Clinical, laboratory, and imaging data were collected using standardized procedures during a single screening visit in Rome, Italy. Hepatic steatosis was defined by controlled attenuation parameter (CAP) or ultrasound-based Hamaguchi's score. UDFF performance for hepatic steatosis was estimated by the area under the receiver operating characteristic curve (AUC).

RESULTS

Overall, median (IQR) UDFF was 12% (7-20). UDFF was positively correlated with CAP (ρ = 0.73, p < 0.0001) and Hamaguchi's score (ρ = 0.79, p < 0.0001). Independent predictors of UDFF were circulating triglycerides, alanine aminotransferase (ALT), and ultrasound-measured visceral adipose tissue (VAT). UDFF AUC was 0.89 (0.85-0.93) and 0.92 (0.88-0.95) for CAP- and ultrasound-diagnosed hepatic steatosis, respectively. UDFF AUC for hepatic steatosis was higher than those of fatty liver index (FLI), hepatic steatosis index (HSI), CAP-score (CAPS), and ALT (p < 0.0001). Lower age, ALT, and VAT were associated with discordance between UDFF and ultrasound.

CONCLUSIONS

UDFF may be a simple and accurate imaging biomarker to assess hepatic steatosis and monitor changes in hepatic fat content over time or in response to therapeutic interventions beyond clinical trials.

Для цитирования: Tavaglione Federica, Flagiello Valentina, Terracciani Francesca, Gallo Paolo, Capparelli Emma, Spiezia Chiara, De Vincentis Antonio, Palermo Andrea, Scriccia Sara, Galati Giovanni, Napoli Nicola, Daniels Samuel J, Blau Jenny E, Carlsson Björn, Khazrai Yeganeh M, Incalzi Raffaele Antonelli, Picardi Antonio, Vespasiani-Gentilucci Umberto. Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.. Diabetes/metabolism research and reviews. 2024. DOI: 10.1002/dmrr.3787.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.